Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Jul 4, 2013 8:22 PM Flag

    Celldex has 2 potential drugs for blood cancers.

    Management at Celgene could be in panic mode.

    DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
    This study is not yet open for participant recruitment.
    Verified June 2013 by Roswell Park Cancer Institute
    Sponsor:
    Roswell Park Cancer Institute
    Collaborator:
    National Cancer Institute (NCI)
    Information provided by (Responsible Party):
    Roswell Park Cancer Institute

    A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers
    This study is currently recruiting participants.
    Verified May 2013 by Celldex Therapeutics
    Sponsor:
    Celldex Therapeutics
    Information provided by (Responsible Party):
    Celldex TherapeuticsClinicalTrials.gov Identifier:
    NCT01460134
    First received: October 12, 2011
    Last updated: May 23, 2013
    Last verified: May 2013
    History of Changes

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CLDX
27.17+1.21(+4.66%)Mar 27 4:00 PMEDT